Under construction – not a live service
Sign in
Taking people in United KingdomNo phase

Testing ways to improve sleep and cut sitting time in type 2 diabetes

Tests sleep therapy and sitting-reduction coaching in adults with type 2 diabetes.

Plain-language title generated from the registry record
Registry title: A Study Looking to Improve Sleep and Reduce Sedentary Behaviour in Those Living With Type 2 Diabetes Mellitus

Key facts

Where
Leicester, United KingdomSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 75 years old?

Source: NCT06471634, who can take part

Where in United Kingdom

  • Diabetes Research Centre University Hospitals LeicesterLeicester, United KingdomTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
University of Leicester
Trial code
NCT06471634
Record updated
27 March 2025
Original description
The goal of this clinical feasibility trial is to learn whether the investigators can improve sleep and reduce sedentary behaviour in people living with Type 2 diabetes mellitus with sleep problems. The main questions it aims to answer are: • question 1, can objectively measured sleep and sedentary behaviour be improved in the participants and • question 2, what effect will this have on a number of physical and physiological markers. Participants in the intervention group will be asked to keep sleep diaries and attend regular meetings with a qualified coach who will use a specific talking therapy to try to improve sleep and with use behaviour change techniques to help them be less sedentary. Researchers will compare the control group to the intervention group to see if effects differ between groups.Read full original descriptionShow less

An Efficacy Study Exploring the Optimisation of Sleep and the Reduction of Sedentary Behaviour in Those Living With Type 2 Diabetes Mellitus

The goal of this clinical feasibility trial is to learn whether the investigators can improve sleep and reduce sedentary behaviour in people living with Type 2 diabetes mellitus with sleep problems. The main questions it aims to answer are: • question 1, can objectively measured sleep and sedentary behaviour be improved in the participants and • question 2, what effect will this have on a number of physical and physiological markers. Participants in the intervention group will be asked to keep sleep diaries and attend regular meetings with a qualified coach who will use a specific talking therapy to try to improve sleep and with use behaviour change techniques to help them be less sedentary. Researchers will compare the control group to the intervention group to see if effects differ between groups.

Inclusion: Diagnosed with Diabetes Mellitus type 2 for longer than 3 months; Participant is willing and able to give informed consent to take part in the study; Sleep disorder symptom checklist 25 (SDS-CL-25) of ≥5 on insomnia criteria; Not at high risk of undiagnosed Obstructive Sleep Apnoea (OSA), scoring ≥5 on STOP BANG scale (snoring, tired, observed, pressure, body mass index, age, neck size, gender) diagnosed treated OSA is acceptable; Glycated haemoglobin (HbA1c) of 10% or less (86 mmol/mol) or less; Male or Females; ≥ 18 ≤ 75 years of age; Able to walk without the use of an assistive device or requiring assistance from another person; Not undertaking more than 75 minutes a week of strenuous exercise or sport; Not taking opioids; Be treatment stable for at least 3 months; Accelerometer measurement of SE ≤ 85%; An understanding that CBTi may exacerbate sleep deprivation in the short term which may impact on certain aspects of daily life.

Exclusion: Currently on opioids; Individuals with type 1 diabetes or gestational diabetes; Diagnosed with borderline personality disorder, psychosis, adult attention deficit hyperactivity disorder (ADHD) or schizophrenia (self-reported); Individuals living with epilepsy or seizures; Terminal illness; Individuals living with narcolepsy or diagnosed parasomnia; Recent cardiovascular event (within the last 6 months); Shift workers; Female participant planning to become pregnant with the timeframe of the study or is currently pregnant.

ClinicalTrials.gov NCT06471634